负性协同刺激分子参与调控危重症手足口病T细胞功能障碍的机制研究

基本信息
批准号:81460251
项目类别:地区科学基金项目
资助金额:48.00
负责人:农光民
学科分类:
依托单位:广西医科大学
批准年份:2014
结题年份:2018
起止时间:2015-01-01 - 2018-12-31
项目状态: 已结题
项目参与者:蒋敏,韦丹,李燕,李树全,张敏,张艳艳,赵绮,詹文杰,粟颖
关键词:
手足口病T细胞功能障碍T细胞免疫球蛋白粘蛋白分子3
结项摘要

Severe hand, foot and mouth disease (HFMD) caused by enterovirus 71(EV71) has become one of the most critical public health problems due to its high mortality. In July 2012, we published a clinicopathologic study of HFMD in children in NEJM, and this study has proved neurogenic pulmonary edema is the leading cause of death. The previous study further showed that there was T-cell exhaustion and impaired IFN-gamma secretion in severe HFMD, however the mechanism remains unknown. Recent evidence suggests that negative co-stimulatory molecule T cell immunoglobulin and mucin domain (Tim-3) and program death factor-1(PD-1) plays a crucial role in mediating T cell exhaustion or dysfunction both in viral infections. Data from our previous study (unpublish) have identified that high Tim-3 expression was associated with T-cell exhaustion and impaired IFN-gamma secretion in the severe case with pulmonary edema caused by EV71. Based on this finding, we will examine the associations among Tim-3, PD-1 gene polymorphism and the severity of HFMD caused by EV71, and examine the relevant mechanisms of Tim-3, PD-1 expression in T cell, IFN - gamma secretion in EV71 clearance and mixed antagonist response syndrome(MARS) for severe HFMD case with pulmonary edema caused by EV71. This project will reveal the mechanism of negative co-stimulatory molecule involved in regulation of T cell exhaustion or dysfunction in severe case with pulmonary edema caused by EV71, which may provide theoretical basis for developing new therapeutic strategies.

EV71相关危重症手足口病死亡率高,2012年项目组在NEJM发表的临床病理研究证实并发神经源性肺水肿是死亡最主要原因;其体内存在T细胞耗竭及IFN-γ分泌障碍,但机制不明。近来的研究表明负性协同刺激分子Tim-3,PD-1是一些病毒感染性疾病T细胞耗竭/功能障碍的重要机制。我们前期研究首次证实EV71相关肺水肿体内IFN-γ分泌障碍与其高表达Tim-3相关。本项目在此基础上,分析Tim-3,PD-1基因多态性与疾病严重度的相关性;采用临床标本、细胞模型,通过体内检测、体外共培养、细胞转染及功能阻断实验研究EV71能否直接诱导T细胞Tim-3、PD-1表达上调,Tim-3、PD-1及其共同高表达对T细胞凋亡、IFN-γ分泌的调节作用机制,及对EV71清除、混合拮抗反应的影响。本项目初步阐明负性协同刺激分子参与调控EV71相关肺水肿T细胞耗竭/功能障碍的机制,为制定新的治疗策略提供理论依据。

项目摘要

危重症手足口病患儿出现的肺水肿是致死性并发症。近年的研究提示机体T细胞功能状态及异常的炎症反应异常可能与肺水肿的发病有关。本研究前瞻性评估危重症手足口病患儿CD4+ T细胞及其功能状态。研究发现危重症患儿促炎因子IFN-γ、IL-1β、IL-2、IL-6及抑炎因子TGF-β、IL-10水平较S组、M组、NC组显著升高(P<0.05)。危重症中死亡组IL-8、IL-18、IL-10水平较存活组显著升高(P<0.05)。危重症组IL-10、GM-CSF在病程的第4-6天水平高于在病程1-3天水平。危重症组全血IFN-γ释放功能减低;危重症组干扰素释放指数与CD4+T细胞(%)呈正相关 (r=0.578, P=0.049)。IL-8、IL-10、IL-18水平升高是病情加重的预警信号。危重症HFMD患儿处于代偿性抗炎反应或混合性拮抗反应状态,可能与CD4+T细胞功能障碍/耗竭有关。我们进一步探讨负性协同刺激因子在危重症手足口病发病中的作用。HFMD患儿外周血CD4、CD8T细胞表面表达PD1、Tim-3比例显著上调,并且与疾病严重程度有关,危重症表达PD1、Tim-3比例最高;高表达的PD1、Tim-3支持危重症手足口病存在T细胞功能障碍/耗竭。Tim-3负性调节CD4、CD8T细胞分泌IFN-γ功能,体外单一阻断Tim-3信号或联合PD1、Tim-3阻断通路可以改善危重症患儿T细胞分泌IFN-γ功能。本课题为危重症手足口病发病机制的研究提供新的思路,也为危重症手足口病潜在的免疫调控治疗措施提供理论依据和数据支持。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction

Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction

DOI:10.1080/15287394.2018.1502561
发表时间:2018
2

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

DOI:
发表时间:2016
3

基于 Kronecker 压缩感知的宽带 MIMO 雷达高分辨三维成像

基于 Kronecker 压缩感知的宽带 MIMO 雷达高分辨三维成像

DOI:10.11999/JEIT150995
发表时间:2016
4

伴有轻度认知障碍的帕金森病~(18)F-FDG PET的统计参数图分析

伴有轻度认知障碍的帕金森病~(18)F-FDG PET的统计参数图分析

DOI:10.3760/cma.j.issn.0376-2491.2018.33.004
发表时间:2018
5

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

DOI:10.1080/15476286.2017.1377868.
发表时间:2017

农光民的其他基金

相似国自然基金

1

影响手足口病感染和疾病严重程度的T细胞免疫机制

批准号:81172807
批准年份:2011
负责人:冷启彬
学科分类:H1104
资助金额:60.00
项目类别:面上项目
2

手足口病流行时空预测研究

批准号:81860605
批准年份:2018
负责人:洪志敏
学科分类:H3011
资助金额:35.00
项目类别:地区科学基金项目
3

EV71诱导的pDC功能缺陷与CAP活化在危重症手足口病中的作用研究

批准号:81560262
批准年份:2015
负责人:李莉
学科分类:H1104
资助金额:39.00
项目类别:地区科学基金项目
4

手足口病重症病例影响因素的分子流行病学研究

批准号:81172740
批准年份:2011
负责人:段广才
学科分类:H3009
资助金额:62.00
项目类别:面上项目